Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis.
about
Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal modelsNaturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.CD4(+) T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs.
P2860
Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Hypervariable region 1 variant ...... oring CD95-mediated apoptosis.
@en
Hypervariable region 1 variant ...... oring CD95-mediated apoptosis.
@nl
type
label
Hypervariable region 1 variant ...... oring CD95-mediated apoptosis.
@en
Hypervariable region 1 variant ...... oring CD95-mediated apoptosis.
@nl
prefLabel
Hypervariable region 1 variant ...... oring CD95-mediated apoptosis.
@en
Hypervariable region 1 variant ...... oring CD95-mediated apoptosis.
@nl
P2860
P50
P356
P1476
Hypervariable region 1 variant ...... voring CD95-mediated apoptosis
@en
P2093
Enza Piccolella
P2860
P304
P356
10.1189/JLB.0804456
P577
2005-05-27T00:00:00Z